The mechanisms and regulation of procathepsin L secretion from osteoclasts in bone resorption  by Tagami, Kahori et al.
ELSEVIER 
FEBS Letters 342 (1994) 30&312 
FEBS 13869 
The mechanisms and regulation of procathepsin 
osteoclasts in bone resorption 
RRHB 
LETTERS 
L secretion from 
Kahori Tagami”, Hisao Kakegawab, Hiroshi Kamioka”, Koji Sumitani”, Terushige Kawataa, 
Brigita LenarEiE”, Vito Turk”, Nobuhiko Katunumaby* 
aDepartment of Orthodontics, School of Dentistry, The University of Tokushima, Kuramoto-cho, Tokushima 770, Japan 
bInstitute for Health Sciences, Tokushima Bum+ University, Yamashiro-cho, Tokushima 170. Japan 
‘De~rtment of Biochemistry, J. Stefan Institute, Jamova, 39, 4~000 ~jab~a~, SIovenia 
Received 28 February 1994 
Abstract 
The secretion mechanisms of cathepsin L from osteoclasts in the process of bone resorption were investigated. The increases in bone pit numbers 
formed take place by PTH addition in parallel with the increases of cathepsin L and/or L-like proteinase activities in the culture medium of bone 
cells, and these were suppressed by the addition of calcitonin. The Z-Phe-Arg-MCA hydrolysing activity increased in the medium through the effect 
of F’TH is considered to be a kind of procathepsin L by Western blotting analysis, and was suppressed by calcitonin addition. Furthermore, monensin 
inhibited not only the PTH-induced pit formation, but also cysteine proteinase activity in osteoclasts. Therefore, the procathepsin L excreted might 
be transferred from endothelial reticulum via Golgi and/or via lysosomes. 
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1. Introduction 
The degradation of the bone organic matrix mainly 
consisting of collagen during the process of bone resorp- 
tion occurs in the extracellular acidified microenviron- 
ment (Howship’s lacuna) under the ruffled border of the 
osteoclasts [la]. Recently, lysosomal cysteine pro- 
teinases in osteoclasts, especially cathepsins L and B, 
have been thought to participate in the osseous col- 
lagenoiysis [2,49]. Kominami et al. immunohistocherni- 
tally demonstrated the presence of cathepsin B and L in 
rat osteoclasts of the bone surface, suggesting the partic- 
ipation of these proteinases in the degradation of the 
organic constituents of the bone matrix [9]. We previ- 
ously reported that rat osteoclastic bone resorption in- 
duced by parathyroid hormone (PTH) was markedly in- 
*Corresponding author. Fax: (81) (886) 22 3217. 
Abbreviations: Z, benzyloxycarbonyl; MCA, methylcoumarylamide; 
E-64-a, N-(L-3-transcarboxyoxirane-2-carbonyl)-L-leucine~-aminobu- 
tyl-amine; CA-074, N-(L-3-trans-propyl-carbamoyloxirane-2-car- 
bony])-L-isoleucyl-L-proline. 
Enzymes: cathepsin B, EC 3.4.22.1; cathepsin L, EC 3.4.22.15. 
hibited by pig leucocyte cysteine proteinase inhibitor 
(PLCPI) [IO,1 I], a specific inhibitor of cathepsin L, and 
by chymos~tin, a selective inhibitor of cathepsin L, but 
not by CA-074 1121, a specific inhibitor of cathepsin B 
[13]. These facts suggest hat cathepsin L or L-like pro- 
teinase, including procathepsin L, is the main proteinase 
responsible for bone collagen degradation. 
It is important to clarify the individual functions of the 
various cells responsible for the secretion of cysteine pro- 
teinases related to bone resorption, such as osteoclasts, 
osteoblasts and osteocytes. The lysosomal cysteine pro- 
teinases of osteoclasts are synthesized in the endothelial 
reticulum and transported via Golgi toward the ruffled 
border membrane and secreted into the bone resorbing 
lacuna [l-4]. Everts et al. indicated that the release of 
j%glucronidase as a marker of the exocytosis of lyso- 
somal enzymes induced by PTH in the mouse calvarial 
system and the amount of calcium released in the me- 
dium were both significantly decreased in the presence 
of calcitonin, which binds to the receptor on the surface 
of osteoclasts to suppress osteoclastic bone resorption 
[14]. The aim of the present work is to clarify the mech- 
anisms of PTH-induced secretion of collagenolytic yste- 
ine proteinases into the culture medium. We investigated 
the relationship between pit formation and the increase 
in cysteine proteinase activity induced by PTH into the 
culture medium of rat bone marrow cells, and the sup- 
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pression of these phenomena by calcitonin. Further- 
more, the effect of monensin [15,16] on rat osteoclastic 
bone resorption induced by PTH was evaluated. 
2. Experimental 
2.1. Materials 
Z-Phe-Arg-MCA was purchased from the Peptide Institute (Osaka, 
Japan). E-64-a and CA-074 were kindly supplied by Taisho Pharmaceu- 
tical Co., (Saitama, Japan). PLCPI was prepared as described previ- 
ously [lO,l 11. Fetal bovine serum (FBS) was from Gibco (Grand Island, 
NY), while human PTH (l-34) and salmon calcitonin were from Pen- 
insula Laboratories Inc. (Behnond, CA). Monensin was from Wako 
Pure Chemical Co., Osaka. All other chemicals were of analytical 
grade. Rat liver cathepsin L was purified according to the published 
procedure [19]. Rabbit anti-cathepsin L was donated by Dr. E. Komi- 
nami (Department of Biochemistry, Juntendo University School of 
Medicine, Japan). Sprague-Dawley (SD) rats (l-2 days old) were used 
for preparation of unfractionated bone cells, and male SD rats (68 
weeks old) were purchased from Charles River, Japan. Bovine com- 
pacted bone slices (150 pm thick) were punched out as circles 6 mm in 
diameter. Goat anti-mouse IgG labeled alkaline phosphatase (ALP) 
was purchased from EY Laboratories Inc. 
2.2. Enzyme assay 
Cathepsin activities were measured with Z-Phe-Arg-MCA at pH 5.5, 
as described nreviouslv 1131. Brieflv. E-64. CA-074 and PLCPI were 
preincubatedwith et&&e and the reactions were started by the addi- 
tion of substrates. The fluorescence of 7-amino-4-methylcoumrin liber- 
ated from the substrate was monitored by a fluorescence spectrometer 
(Hitachi F-2000). 
2.3. Assay of bone resorption 
The bone resorption assay was carried out according to the method 
of Mcsheehy and Chambers [18], with certain modifications as de- 
scribed previously. For the preparation of bone cells, the long bones 
from l- to 2-day-old Sprague-Dawley rats were minced by scissors in 
alpha minimum essential medium (a-MEM, Flow Laboratories, 
McLean, VA) containing 10% FBS. Two-hundred ~1 of the cell suspen- 
sion (1 x lo6 cells per well) were added to each well of a 96-well plate 
containing a bovine bone slice in each well, and the cells were incubated 
at 37°C in a CO, incubator for 40 min. After the slices were rinsed with 
u-MEM, five slices were transferred to 500,ul of fresh medium contain- 
ing 100 nM of PTH and 1 or 10 nM of calcitonin but not containine 
FBS in each well of a 24-well plate, and were incubated for 2472 c 
Osteoclast-induced pits on slices were stained with acid hematoxylin for 
5 min. The total area of pits was measured under an optical microscope. 
2.4. Cysteine proteinase activity in rat osteoclasts and macrophages 
Rat osteoclasts were purified according to the method of Tezuka et 
al. as described previously [13]. After purification, 90% of cells were 
multinucleate and had tartrate-resistant acid phosphatase activity. Rat 
peripheral macrophages were obtained from whole blood of male SD 
rats. The blood was collected into heparinized tubes from the aorta 
descendens, and centrifuged at 900 rpm for 15 min. After removal of 
the platelet fraction, the buffy coat was collected, and then diluted 1:4 
with RPM1 1640 containing 100 units of kanamycin. The diluted buffy 
coat was layered onto the lymphocyte separation medium (LymphoSep, 
ICN Flow, Norway), and centrifuged at 900 rpm for 20 min. The 
leucocyte fraction collected was suspended in RPM1 1640 containing 
10% fetal bovine serum, and transferred to 100~nm culture dishes, and 
incubated at 37°C in a CO, incubator (5% CO,/958 air) for 2 h. 
Non-adherent cells were then removed by‘washing the cells’five times 
with phosphate-buffered saline (PBS; 136 mM NaCl, 2.7 mM KCI, 8.1 
mM Na,HPO,, and 1.5 mM KH,POd. The isolated cells were soni- 
cated, and centrifuged. Each supernatant was provided to the assay. 
The cysteine proteinase activities in the supernatants were assayed as 
described above. Protein concentration in a supernatant was deter- 
mined by the BCA method (Pierce Chemical. Co., Rockford, IL), with 
bovine serum albumin as a standard. 
2.5. Effect of monensin on Z-Phe-Arg-MCA hydrolytic activities in rat 
osteoclasts 
Rat bone marrow cells prepared as described above were incubated 
in a 100~mm dish (CORNING, NY) in a-MEM containing 10% FBS, 
50 nM of PTH and 1 x lo-* M of monensin for 24 h at 37°C in a CO, 
incubator. Osteoclasts were then purified and the Z-Phe-Arg-MCA 
hydrolytic activity in the cells was measured as described above. 
2.6. Gel electrophoresis and western blotting analysis 
SDS-PAGE was carried out by the method of Laemmli [19] in a 
15-258 gradient gel containing 0.1% SDS at room temperature. The 
SDS-PAGE low-range standards (Bio-Rad, Richmond) used as molec- 
ular weight markers were phosphorylase B (106 kDa), BSA (80 kDa), 
ovalbumin (49.5 kDa), carbonic anhydrase (32.5 kDa), soybean trypsin 
inhibitor (27.5 kDa) and lysozyrne (18.5 kDa). For Western blot anal- 
ysis, the media were concentrated 40 times, subjected SDS-PAGE, and 
transferred electrophoretically to an Immobilon transfer membrane 
(Milipore). Immunoblotting was developed using a 1:2000 dilution of 
rabbit anti-rat cathepsin L as the first antibody, and bound antibodies 
were detected by goat anti-IgG Fab’-conjugated alkaline phosphatase. 
The alkaline phosphatase reaction was performed using Picoblue Im- 
munoscreening Kits (Stratagene, CA). 
3. Results and discussion 
3.1. Cysteine proteinase activities of osteoclasts in 
comparison with those of macrophages 
The contents of various cysteine proteinases in osteo- 
clasts using Z-Phe-Arg-MCA hydrolytic activities were 
compared with those of macrophages using their homo- 
genates from the isolated osteoclasts and macrophages. 
Specific inhibitors for individual cathepsins were used to 
determine the contents of respective cathepsins, such as 
CA-074 [12], a specific inhibitor of cathepsin B, E-64 
[20], a general inhibitor cysteine proteinases, and pig 
leucocyte cysteine proteinase inhibitor (PLCPI) [ 10,111, 
a specific inhibitor of cathepsin L and cathepsin L-like 
proteinase. The results are shown in Table 1. 
The value of the activity in the presence of 1 x 10m7 M
of CA-074 subtracted from the total activity was 0.62 
mU/mg, which corresponds to the activity of cathepsin 
Table 1 
The characteristic profiles of Z-Phe-Arg-MCA hydrolytic activities of 
rat osteoclasts and macrophages 
Z-Phe-Arg-MCA hydrolytic activities 
(mU/mg) 
Inhibitor Osteoclasts Macrophages 
None 1.48 1.53 
CA-074” 0.86 0.14 
E-64s 0.56 0.09 
E-64’ 0.11 0.03 
CA-074” + PLCPIb 0.48 0.06 
“1 x lo-‘M, bl x 1O-6 M, ‘1 x lO-5 M. 
The values of the activities in the presence of 1 x lo-’ M of CA-074 
subtracted from those in the absence of inhibitors correspond to cathep- 
sin B activities. The values of the activities in the presence of 1 x 10v6 
M of E-64 subtracted from those in the presence of 1 x lo-’ M of 
CA-074 correspond to cathepsin L and/or L-like proteinase activities. 
One unit corresponds to the production of 1 pmol methylcoumarylam- 
ine per min. 
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B, since CA-074 of this concentration inhibits only 
cathepsin B among all cysteine proteinases. The value of 
the activity in the presence of 1 x 10e6 M of E-64 sub- 
tracted from that in the presence of 1 x lo-’ M of CA- 
074 was 0.30 mU/mg, which was totally inhibited by 
1 x 10e6 M of PLCPI, a specific inhibitor of cathepsin L 
and L-like proteinase. It has been established that 
1 x 10T6 M of E-64 almost completely inhibits both activ- 
ities of cathepsins B and L, but not cathepsin J. These 
facts indicate that this part in Z-Phe-Arg-MCA hydro- 
lytic activities corresponds to the activity of cathepsin L 
and/or L-like proteinase. The remaining activity in the 
presence of 1 x 10e6 M of E-64 was 0.56 mU/mg, which 
was inhibited by a higher concentration of E-64, indicat- 
ing that this part of activity may be due to the activity 
of cathepsin J [21], which has been reported to be inhib- 
ited by more than 1 x 10m6 M of E-64, and/or the un- 
known cysteine proteinases. It is established that macro- 
phages and osteoclasts are differentiated from the same 
origin, granulo-monocyte colony forming units (GM- 
CFU). In the case of macrophages, the value of total 
Z-Phe-Arg-MCA hydrolytic activity minus the remain- 
ing activity with CA-074 was 1.39 mU/mg, which corre- 
sponds to cathepsin B. On the other hand, the activities 
of cathepsin L and/or L-like proteinase were minimal. 
The contents of cathepsin L and/or L-like proteinase in 
osteoclasts are far more abundant than those in macro- 
phages, although both osteoclasts and macrophages are 
differentiated from the same origin. These results sup- 
port the important role of cathepsin L and/or L-like 
proteinase in bone resorption. 
Table 2 
Correlation between Z-Phe-Arg-MCA hydrolytic activities in culture 
medium of rat bone cells and bone resorption 
Z-Phe-Arg-MCA hydrolytic activities (mu/ml) 
Inhibitor PTH minus PTH plus PTH and calci- 
tonin plus 
None” 6.85 * 1.33** 14.00 + 2.16 9.15 f 1.01** 
None - CA-074b 4.29 f 0.94** 9.68 ?r 1.69 6.12? 1.03** 
CA-074 - E-64’ 1.43 f 0.16** 2.50 + 0.44 1.55 f 0.17** 
Bone resorption (number of pits/bone) 
PTH minus PTH plus PTH and calci- 
tonin plus 
211.8 2 73.5** 668.4 f 94.3 133.7 f 41.1** 
B Corresponding to total cysteine proteinase activities. %orresponding 
to cathepsin B activity. Corresponding to cathepsin L and/or L-like 
proteinase activities. Concentrations of CA-074 and E-64 were 1 x lo-’ 
and 1 x 10m6 M, respectively. Each value ofZ-Phe-Arg-MCA hydrolytic 
activity indicates the mean f S.D. of 5 observations. Each value of bone 
resorption indicates the mean f S.D. of 20 observations. **P < 0.01; 
significant difference from PTH-plus-group (Student’s t-test). Concen- 
trations of PTH and calcitonin were 1 x lo-’ and 1 x lo-’ M, respec- 
tively. 
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Fig. 1. Western blot analysis by anti-cathepsin L antibody on bone 
culture medium including PTH and calcitonin. (a) rat liver cathepsin 
L (heavy chain). (b) PTH-minus-group, (c) PTH-plus-group, (d) PTH 
and calcitonin-plus-group. Concentrations of PTH and calcitonin were 
1 x 10m7 and 1 x lO-7 M, respectively. 
3.2. Regulation of cysteine proteinase secretion by PTH 
and calcitonin 
In the processes of bone resorption, the release of 
cathepsin L and/or L-like proteinase from osteoclasts 
seem to be essential processes. Vaes et al. have shown 
that several inhibitors of cysteine proteinases, such as 
leupeptin, antipain, tosyl-lysyl chloromethane (Tos- 
Lys-CH,Cl), benzyloxycarbonyl-phenylalanyl-alanyl-di- 
azomethane (Z-Phe-Ala-CHN,) and E-64, markedly in- 
hibited PTH-induced bone resorption in cultured mouse 
bone cells [4-61. Moreover, we reported that the bone pit 
formation induced by PTH was-strongly suppressed by 
PLCPI, a specific inhibitor of cathepsin L and/or L-like 
proteinase, and chymostatin, a selective inhibitor of 
cathepsin L, while no inhibition was observed by CA- 
074, a specific inhibitor of cathepsin B [13]. However, so 
far, there has been no apparent evidence that cathepsin 
L and/or L-like proteinase are secreted from the cells 
induced by PTH. Therefore, we subsequently examined 
the parallel movements of increases in the activities of 
cathepsins in culture medium and pit formation induced 
by PTH. The effects of calcitonin on both cases were also 
investigated. In the experiments, fetal bovine serum was 
not added to the medium, because FBS contains some 
inhibitors of cysteine proteinases. As shown in Table 2, 
the Z-Phe-Arg-MCA hydrolytic activity in the medium 
of the PTH-plus-group significantly increased 30 h after 
treatment with PTH, in contrast with that of the PTH- 
minus-group. Furthermore, both the values of the activ- 
ity with CA-074 subtracted from total activity, corre- 
spond to cathepsin B activity, and the value of the activ- 
ity in the presence of E-64 subtracted from that with 
CA-074, corresponds to cathepsin L and/or L-like pro- 
teinase activities, and are significantly elevated after the 
addition of PTH. The numbers of pit formation were 
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Fig. 2. Intluence of monensin on the bone resorption inducted by PTH and the Z-Phe-Arg-MCA hydrolytic activities in rat osteoclasts. Each value 
of bone resorption indicates the mean f S.D. of 5 observations. **P < 0.01; significant difference from monensin-minus-group (Student’s r-test). 
Concentrations of PTH and monensin were 5 x 10-s and 1 x lo-* M. respectively. 
stimulated by PTH approximately 3-fold more than that 
of the PTH-minus-group. On the other hand, 1 x lob7 M 
of calcitonin significantly suppressed the increases in 
both the cysteine proteinase activities secreted into the 
media and the pit formation stimulated by PTH. These 
results agree with the fact that calcitonin inhibits the 
release of both calcium, as a marker of bone resorption, 
and j?-glucuronidase, as a marker of the exocytosis of 
lysosomal enzymes induced by PTH, from calvaria of 
mice into the cultured medium 1141. Calcitonin com- 
pletely inhibited not only PTH-induced pit fo~ation but 
also spontaneous bone resorption, while the increases in 
cysteine proteinase activities induced by PTH were una- 
ble to be inhibited by calcitonin to the level of the PTH- 
minus-group. This indicates that calcitonin can inhibit 
several functions of osteoclasts on the secretion of cyste- 
ine proteinases. These results suggest hat PTH might 
induce secretion of lysosomal enzymes including cathep- 
sin L from osteoclasts to degrade the osseous organic 
matrix. 
3.3. The ~entl~cat~on f procat~e~si~ L secreted into the 
culture medium 
Identification of the forms of cathepsin L and/or L- 
like proteinase in culture medium using Western blot 
analysis with rat anti-cathepsin L antibodies was carried 
out. As shown in Fig. 1, a 39 kDa protein was detected 
as a procathepsin L. The content of this proteinase se- 
creted into the medium was significantly increased by 
addition of PTH, and the increase in secretion of pro- 
cathepsin L induced by PTH was markedly suppressed 
by calcitonin. The bone resorption was equivalent o the 
secreted amounts of procathepsin L. A large number of 
calcitonin receptors were detected in osteoclasts, but not 
in osteoblasts [ZZ]. Therefore it is possible to consider 
that procathepsin L might be secreted from osteoclasts, 
but not from osteoblasts. Procathepsin L secreted from 
osteoclasts is thought to be converted to the mature form 
by autolysis in the extracellular acidified lacuna, because 
when the 39 kDa proform partially purified from the 
bone of rats receiving a low calcium diet was incubated 
in acidic buffer, this enzyme was efficiently converted to 
mature cathepsin L (data is not shown). 
3.4. Effect of monens~n o  pit formation and cysteine 
proteinase activity in rat osteoclasts 
Furthermore, the effects of monensin [15,16] on the 
bone resorption induced by PTH and on the Z-Phe-Arg- 
MCA hydrolytic activity in isolated osteoclasts were in- 
vestigated. As shown in Fig. 2, 1 x lo-* M of monensin 
completely inhibited not only the PTH-induced pit for- 
mation but also the Z-Phe-Arg-MCA hydrolytic.activi- 
ties in osteoclasts. Since monensin itself does not inhibit 
cysteine proteinase activity, but inhibits the targetting of 
cystein proteinases into lysosomes to prevent the excre- 
tion of the cathepsins, the decreases in cathepsin L activ- 
ities may result in the in~bition of translocation of the 
cysteine proteinases in the cells. These results confirm 
that the lysosomal cysteine proteinases in osteoclasts and 
their secretion from the cells may play an important role 
in the process of bone resorption. 
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